YXG-158
YXG-158 (Compound 23-h) is an orally bioavailable small molecule that degrades the androgen receptor (DC50 = 1.28 μM) and inhibits CYP17A1 (IC50 = 100 nM) . It is a candidate research tool for investigating therapeutic strategies against castration-resistant and enzalutamide-resistant prostate cancer models.
Product Specifications
CAS Number
2952994-34-0
Field of Research
Metabolism Research
Smiles
C[C@@]12[C@] ([C@]3 ([C@@] ([C@]4 (C) C (=CC3) C[C@@H] (NC (=O) C5=CC=C (F) C=C5) CC4) (CC1) [H]) [H]) (CC=C2N6C=C (C) N=C6) [H]
Molecular Formula
C30H36FN3O
Molecular Weight
473.62
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS566867-01 0.1 mg
MART-1 Recombinant monoclonal antibody (MLANA/1409R)
Sign In for Pricing
View Details 
MBS566867-02 5x 0.1 mg
MART-1 Recombinant monoclonal antibody (MLANA/1409R)
Sign In for Pricing
View Details 